Barbara Fiorini Due
@Novo Holdings A S
Latest period2024 - Q3ReportedManaged Assets$2.013BTotal holdings37
Assets growth rate8.55%Assets growth rate (2-Q avg)18.26%Continuous growth in asset value2 quarters
Portfolio positions
This chart displays the top 10 holdings in Novo Holdings A S's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 37 positions.
Assets under management
The assets under management (AUM) of Novo Holdings A S over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.013B in assets, with a quarterly growth rate of 8.55% and a 2-quarter average growth rate of 18.26%. The portfolio is managed by Barbara Fiorini Due, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
KYTXKyverna Therapeutics Inc
| 0.45% | $9.046M 1.85M shares@ $4.89 avg price | Increased 5.72% |
MGXMetagenomi Inc
| 0.2% | $3.906M 1.8M shares@ $2.17 avg price | |
IOBTIo Biotech Inc
| 0.18% | $3.522M 3.354M shares@ $1.05 avg price | Decreased -24.26% |
ABCLAbcellera Biologics Inc
| 0.15% | $2.93M 1.127M shares@ $2.6 avg price | |
MQMarqeta Inc
| 0.11% | $2.172M 441,558 shares@ $4.92 avg price | |
GLTOGalecto Inc
| 0.07% | $1.214M 99,913 shares@ $12.16 avg price | New Position |
SPROSpero Therapeutics Inc
| 0.04% | $628,329 468,902 shares@ $1.35 avg price |